(Q33815830)

29 July 2017

0 references

1 reference

title

Efficacy of treating hypertension in women (English)

1 reference

29 July 2017

2

Kerlikowske K

1 reference

29 July 2017

Quan A

1

1 reference

29 July 2017

Gueyffier F

series ordinal

3

1 reference

29 July 2017

Boissel JP

series ordinal

4

1 reference

29 July 2017

1 December 1999

1 reference

Journal of General Internal Medicine

29 July 2017

1 reference

29 July 2017

14

1 reference

29 July 2017

12

1 reference

29 July 2017

718-729

1 reference

https://scigraph.springernature.com/pub.10.1046/j.1525-1497.1999.12198.x

29 July 2017

0 references

cites work

Cardiovascular health and disease in women

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Hypertension in women: current understanding of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Hypertension in the elderly. Implications and generalizability of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Factors influencing the age at natural menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Number needed to treat is a simple measure of treatment efficacy for clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Using numerical results from systematic reviews in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Alterations in canine myocardial excitability during ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council o

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Cardiovascular risk factors, premature heart disease, and all-cause mortality in a cohort of Northern California women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Management of raised blood pressure in New Zealand: a discussion document

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Blood pressure management: individualized treatment based on absolute risk and the potential for benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

The impact of age on the cost-effectiveness of hypertension treatment: an analysis of randomized drug trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

MENSTRUAL AND REPRODUCTWE CHARACTERISTICS AND AGE AT NATURAL MENOPAUSE

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

Pulling it all together: Changing the cardiovascular outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1497.1999.12198.X

10.1046/J.1525-1497.1999.12198.X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference